RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Liquidia Technologies, a privately held biopharmaceutical company developing particle-based vaccines and therapeutics, announced today that Jonathan F. Smith, Ph.D., has joined the company as Chief Scientific Officer.
